As your expert extension, Evestia Clinical offers dedicated support within the challenging field of Neurology clinical trials.
We understand the intricate scientific demands of this area and are committed to collaborating with biotech partners to drive meaningful outcomes for patients. Our experienced teams bring valuable insights, with a strong foundation built on managing complex trials, including overlaps between specific neurological conditions and oncology, such as neurological cancers.
We leverage our expertise and transferable skills gained from extensive work in areas like oncology and rare diseases to navigate the nuances of your neurology studies with agility and a focus on delivering robust data.
Emphasizing a partnership approach, we function as an expert extension of your team, ensuring clear communication and shared objectives.
Our commitment includes providing stable, dedicated teams with accessible leadership to foster continuity and strong collaboration throughout your neurology research journey.
Our direct experience across the full spectrum of neurology indications is strong and constantly growing, building upon our regulatory rigor and proven ability to handle scientific complexity, together making us a valuable partner in advancing your neurology therapeutics.
Our neuroscience experience spans both adult and pediatric populations, with more than 60 studies collectively informing our perspective across the neurology landscape. Currently, 34% of our team brings direct neurology-specific experience, contributing insights into the unique clinical, operational, and regulatory challenges that define this space.
This growing foundation — combined with our therapeutic crossover knowledge in oncology and rare disease — enables us to design and deliver neurology studies with the precision, flexibility, and depth required to support even the most complex programs.
Your neurological research deserves to be managed by the most expert, trusted hands. We understand the complexities of this therapeutic area and are committed to helping biotech companies advance innovative treatments. Leveraging our agility and deep expertise gained from managing complex trials in neurology and rare diseases, we are well-equipped to navigate the specific challenges of these studies — such as understanding the disease biology, the management of patients with the most debilitating diseases, controlling variability of assessments, and ensuring patient and caregiver focused solutions.
We approach every study with a high level of individuation and commitment to the success of sponsors, patients and treatments. While our direct portfolio of neurology trials is evolving, our foundational strength lies in our patient-centric approach, rigorous methodologies, and commitment to quality, all of which are directly applicable to neurology research.
We prioritize collaborative partnerships, functioning as a seamless extension of your organization to ensure transparent communication, shared goals, and dedicated support throughout your development program.
Our focus includes providing stable, experienced teams with accessible leadership, and fostering strong and enduring partnerships.
We apply our proven ability to handle scientific complexities and regulatory landscapes to ensure your neurology studies are conducted with precision and efficiency, driving toward meaningful results for patients.
- Experience in neurology and neurodegenerative disease trials since 2004
- Advised as needed by our Scientific Advisory Board and key opinion leaders
- All phases including First-in-Man and Proof of Concept
- Strong relationships with leading clinical trial sites
- Single-site early phase to Phase III coverage
- Act as an extension of Sponsor study team
- Experience includes ALS, Huntington’s, Parkinson’s and Dementia
- Strong focus on ALS with over 1100 patients at 120 sites in 16 countries
- Track record backed by Sponsor referrals
